Author | Julian Upton

Julian Upton is Pharmaceutical Executive’s European and Online Editor. He can be reached at jupton@mjhlifesciences.com

Articles

Merck’s Latest Shot Against Shingles

Pharmaceutical Executive

Article

New DTC campaign for its vaccine Zostavax uses a more serious, personal messaging approach-as pharmas look to close the conversation gaps between patients and healthcare providers.

Pfizer’s AZ Bid Draws Mixed UK Reaction

Pharmaceutical Executive

Article

The confirmation of Pfizer’s bid for an outright acquisition of AstraZeneca has drawn mixed reactions from the UK.

Six Steps to Better Cancer Care in Europe

Pharmaceutical Executive

Article

A report published yesterday provides recommendations for combating the “significant inequalities” affecting access to quality cancer care in Europe.

NICE's Tarceva Decision "Perverse", Says Roche

Pharmaceutical Executive

Article

The UK National Institute for Health and Care Excellence’s (NICE) decision that relapsed non-small cell lung cancer patients should no longer have access to Roche’s cancer pill Tarceva (erlotinib) is a setback for lung cancer care in England and Wales.